The expression of HER-2/neu (c-erbB2), survivin and cycline D1 in serous ovarian neoplasms: their correlation with clinicopathological variables

dc.contributor.author	Turan, G.
dc.contributor.author	Usta, C.S.
dc.contributor.author	Usta, A.
dc.contributor.author	Kanter, M.
dc.contributor.author	Tavli, L.
dc.contributor.author	Karacan, M.
dc.contributor.author	Celik, C.
dc.contributor.author	Eser, M.
dc.date.accessioned	2021-12-21T08:41:43Z
dc.date.available	2021-12-21T08:41:43Z
dc.date.issued	2014
dc.identifier.issn	15672379
dc.identifier.uri	https://doi.org/10.1007/s10735-014-9591-2
dc.identifier.uri	http://dspace.yeniyuzyil.edu.tr:8080/xmlui/handle/20.500.12629/1500
dc.description.abstract	Ovarian cancer is the most common cause of death among all gynecologic malignancies and a result of complex interaction of multiple oncogenes and tumor suppressor genes. The aim of this study was to evaluate expression of HER-2/neu (c-erbB2), survivin and
dc.language.iso	English
dc.publisher	Kluwer Academic Publishers
dc.title	The expression of HER-2/neu (c-erbB2), survivin and cycline D1 in serous ovarian neoplasms: their correlation with clinicopathological variables
dc.type	Article
dc.relation.journal	Journal of Molecular Histology
dc.identifier.issue	6
dc.identifier.startpage	679
dc.identifier.endpage	687
dc.identifier.volume	45
dc.identifier.doi	10.1007/s10735-014-9591-2
dc.relation.issue	6
dc.relation.volume	45